Secondary CNS myeloma with remission after systemic CNS-penetrating agents

BACKGROUND: CNS myeloma is a rare manifestation of multiple myeloma and is often associated with a dismal prognosis; however, cases are increasing in frequency as overall survival improves for MM. There is currently no standardized treatment for CNS myeloma; however, different chemotherapy and radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandez, Luis G, Oyon, Daniel Eduardo, Gondi, Vinai, Grimm, Sean, Khan, Osaama H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307102/
https://www.ncbi.nlm.nih.gov/pubmed/35892045
http://dx.doi.org/10.1093/noajnl/vdac106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307102/
https://www.ncbi.nlm.nih.gov/pubmed/35892045
http://dx.doi.org/10.1093/noajnl/vdac106

Ejemplares similares